TY - JOUR
T1 - Genome-wide association and Mendelian randomisation analysis provide insights into the pathogenesis of heart failure
AU - Shah, Sonia
AU - Henry, Albert
AU - Roselli, Carolina
AU - Lin, Honghuang
AU - Sveinbjörnsson, Garðar
AU - Fatemifar, Ghazaleh
AU - Hedman, Åsa K
AU - Wilk, Jemma B
AU - Morley, Michael P
AU - Chaffin, Mark D
AU - Helgadottir, Anna
AU - Verweij, Niek
AU - Dehghan, Abbas
AU - Almgren, Peter
AU - Andersson, Charlotte
AU - Aragam, Krishna G
AU - Ärnlöv, Johan
AU - Backman, Joshua D
AU - Biggs, Mary L
AU - Bloom, Heather L
AU - Brandimarto, Jeffrey
AU - Brown, Michael R
AU - Buckbinder, Leonard
AU - Carey, David J
AU - Chasman, Daniel I
AU - Chen, Xing
AU - Chen, Xu
AU - Chung, Jonathan
AU - Chutkow, William
AU - Cook, James P
AU - Delgado, Graciela E
AU - Denaxas, Spiros
AU - Doney, Alexander S
AU - Dörr, Marcus
AU - Dudley, Samuel C
AU - Dunn, Michael E
AU - Engström, Gunnar
AU - Esko, Tõnu
AU - Felix, Stephan B
AU - Finan, Chris
AU - Ford, Ian
AU - Ghanbari, Mohsen
AU - Ghasemi, Sahar
AU - Giedraitis, Vilmantas
AU - Giulianini, Franco
AU - Gottdiener, John S
AU - van der Harst, Pim
AU - van Setten, Jessica
AU - Holmes, Michael V
AU - Asselbergs, Folkert W
N1 - Funding Information:
J.B.W., L.B., Xing Chen, C.L.H., M.W.N. and A. Malarstig are current or former employee of Pfizer who may hold Pfizer stock and/or stock options. J.D.B. and J.C. are employees of Regeneron Genetics Center. M.E.D. is an employee of Regeneron Pharmaceuticals. W.M. reports grants and personal fees from Siemens Diagnostics, grants and personal fees from Aegerion Pharmaceuticals, grants and personal fees from AMGEN, grants and personal fees from Astrazeneca, grants and personal fees from Danone Research, personal fees from Hoffmann LaRoche, personal fees from MSD, grants and personal fees from Pfizer, personal fees from Sanofi, personal fees from Synageva, grants and personal fees from BASF, grants from Abbott Diagnostics, grants and personal fees from Numares AG, grants and personal fees from Berlin-Chemie, employment with Synlab Holding Deutschland GmbH, all outside the submitted work. M.L.O. reports grant support from GlaxoSmithKline, Eisai, Janssen, Merck and AstraZeneca. B.M.P. serves on the DSMB of a clinical trial funded by Zoll LifeCor and on the Steering Committee of the Yale Open Data Access Project funded by Johnson & Johnson. V.S. participated in a conference trip sponsored by Novo Nordisk and received a honorarium from the same source for participating in an advisory board meeting. He also has ongoing research collaboration with Bayer Ltd. B.T. is a full-time employee of Servier. S.A.L. receives sponsored research support from Bristol Myers Squibb/Pfizer, Bayer AG and Boehringer Ingelheim, and has consulted for Abbott, Quest Diagnostics and Bristol Myers Squibb/Pfizer. M.V.H. has collaborated with Boehringer Ingelheim in research, and in accordance with the policy of the The Clinical Trial Service Unit and Epidemiological Studies Unit (University of Oxford), did not accept any personal payment. P.T.E. receives sponsored research support from Bayer AG, and has consulted with Bayer AG, Novartis and Quest Diagnostics. D.I.S. is a full-time employee of Bene-volentAI. R.T.L. has received research grants from Pfizer. The remaining authors declare no competing interest.
Publisher Copyright:
© 2020, The Author(s).
Copyright:
Copyright 2020 Elsevier B.V., All rights reserved.
PY - 2020/1/9
Y1 - 2020/1/9
N2 - Heart failure (HF) is a leading cause of morbidity and mortality worldwide. A small proportion of HF cases are attributable to monogenic cardiomyopathies and existing genome-wide association studies (GWAS) have yielded only limited insights, leaving the observed heritability of HF largely unexplained. We report results from a GWAS meta-analysis of HF comprising 47,309 cases and 930,014 controls. Twelve independent variants at 11 genomic loci are associated with HF, all of which demonstrate one or more associations with coronary artery disease (CAD), atrial fibrillation, or reduced left ventricular function, suggesting shared genetic aetiology. Functional analysis of non-CAD-associated loci implicate genes involved in cardiac development (MYOZ1, SYNPO2L), protein homoeostasis (BAG3), and cellular senescence (CDKN1A). Mendelian randomisation analysis supports causal roles for several HF risk factors, and demonstrates CAD-independent effects for atrial fibrillation, body mass index, and hypertension. These findings extend our knowledge of the pathways underlying HF and may inform new therapeutic strategies.
AB - Heart failure (HF) is a leading cause of morbidity and mortality worldwide. A small proportion of HF cases are attributable to monogenic cardiomyopathies and existing genome-wide association studies (GWAS) have yielded only limited insights, leaving the observed heritability of HF largely unexplained. We report results from a GWAS meta-analysis of HF comprising 47,309 cases and 930,014 controls. Twelve independent variants at 11 genomic loci are associated with HF, all of which demonstrate one or more associations with coronary artery disease (CAD), atrial fibrillation, or reduced left ventricular function, suggesting shared genetic aetiology. Functional analysis of non-CAD-associated loci implicate genes involved in cardiac development (MYOZ1, SYNPO2L), protein homoeostasis (BAG3), and cellular senescence (CDKN1A). Mendelian randomisation analysis supports causal roles for several HF risk factors, and demonstrates CAD-independent effects for atrial fibrillation, body mass index, and hypertension. These findings extend our knowledge of the pathways underlying HF and may inform new therapeutic strategies.
KW - Adaptor Proteins, Signal Transducing/genetics
KW - Apoptosis Regulatory Proteins/genetics
KW - Atrial Fibrillation/genetics
KW - Cardiomyopathies/genetics
KW - Carrier Proteins/genetics
KW - Case-Control Studies
KW - Coronary Artery Disease/genetics
KW - Cyclin-Dependent Kinase Inhibitor p21/genetics
KW - Genome-Wide Association Study
KW - Heart Failure/genetics
KW - Humans
KW - Mendelian Randomization Analysis
KW - Microfilament Proteins/genetics
KW - Muscle Proteins/genetics
KW - Risk Factors
KW - Ventricular Function, Left/genetics
UR - http://www.scopus.com/inward/record.url?scp=85077697294&partnerID=8YFLogxK
U2 - 10.1038/s41467-019-13690-5
DO - 10.1038/s41467-019-13690-5
M3 - Article
C2 - 31919418
SN - 2041-1723
VL - 11
SP - 1
EP - 12
JO - Nature Communications
JF - Nature Communications
IS - 1
M1 - 163
ER -